Alpha 2.0
Login Register
» Authors » S Tome

S Tome

Explore the profile of S Tome including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 173
Followers 0
Related Specialties
General Surgery
Gastroenterology
Dentistry
Top 10 Co-Authors
E Otero
E Varo
A Gonzalez-Quintela
J F Castroagudin
M Delgado
R Conde
J Martinez
F R Segade
M Bustamante
I Abdulkader
Published In
Transplant Proc
Rev Asoc Odontol Argent
Rev Esp Enferm Dig
Rev Circ Argent Odontol
Rev Clin Esp
Affiliations
Soon will be listed here.
Recent Articles
1.
A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study
Alvarez J, Baluja A, Selas S, Otero P, Rial M, Veiras S, et al.
Anaesth Intensive Care . 2013 Nov; 41(6):719-27. PMID: 24180712
Liver dysfunction due to a low cardiac output state after cardiac surgery is associated with a poor prognosis, but whether one inotrope is superior to another in improving hepatic perfusion...
2.
Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
Castroagudin J, Molina-Perez E, Ferreiro-Iglesias R, Abdulkader I, Otero-Anton E, Tome S, et al.
Transplant Proc . 2012 Jul; 44(6):1565-7. PMID: 22841215
Introduction: Liver transplantation (OLT) is considered the most efficient therapeutic option for patients with liver cirrhosis and early stage hepatocellular carcinoma (HCC) in terms of overall survival and recurrence rates,...
3.
Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction
Ponton C, Vizcaino L, Tome S, Otero E, Molina E, Castroagudin J, et al.
Transplant Proc . 2010 Mar; 42(2):656-9. PMID: 20304216
Introduction: Calcineurin inhibitors (CNI) are the main pathogenic factors for renal dysfunction in solid organ transplant recipients. Introduction of non-nephrotoxic immunosuppressive drugs, such as mycophenolate mofetil (MMF), may allow discontinuation...
4.
Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence
Castroagudin J, Molina E, Tome S, Otero E, Rodriguez M, Varo E
Transplant Proc . 2009 Apr; 41(3):1003-4. PMID: 19376410
Background: The mammalian target of rapamycin inhibitors are immunosuppressive agents with antiproliferative effects and consequent potential application as anticancer agents. The safety and tolerance of calcineurin inhibitor (CNI)-free sirolimus-based immunosuppressant...
5.
Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience
Castroagudin J, Molina E, Bustamante M, Tome S, Otero E, Martinez J, et al.
Transplant Proc . 2008 Nov; 40(9):2975-7. PMID: 19010164
Background: When restrictive selection criteria are applied orthotopic liver transplantation (OLT) is the most efficient option for the treatment of hepatocellular carcinoma (HCC) in terms of survival and recurrence rate....
6.
Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate
Pascual J, Torrealba J, Myers J, Tome S, Samaniego M, Musat A, et al.
Osteoporos Int . 2007 Apr; 18(10):1435-8. PMID: 17404782
We describe a case of collapsing focal segmental glomerulosclerosis and severe kidney dysfunction in a liver transplant recipient after the initiation of alendronate for osteopenia. In view of the increasing...
7.
Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19
Gonzalez-Quintela A, Garcia J, Campos J, Perez L, Alende M, Otero E, et al.
Alcohol . 2006 Jun; 38(1):45-9. PMID: 16762691
Serum cytokeratin (CK) levels are widely used as tumor markers. Serum levels of CK-18, a tumor marker also known as tissue polypeptide specific antigen (TPS), are increased in patients with...
8.
Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients
Castroagudin J, Ponton C, Bustamante M, Otero E, Martinez J, Tome S, et al.
Transplant Proc . 2006 Jan; 37(9):3965-7. PMID: 16386598
Introduction: Invasive fungal infections are a life-threatening complication in transplant recipients. The prevalence of fungal infection after orthotopic liver transplantation (OLT) is 5% to 42%. The most common isolated pathogens...
9.
Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates
Castroagudin J, Delgado M, Villanueva A, Bustamante M, Martinez J, Otero E, et al.
Transplant Proc . 2006 Jan; 37(9):3871-3. PMID: 16386568
Unlabelled: Orthotopic liver transplantation (OLT) as therapy of hepatocellular carcinoma (HCC) improves the survival of a selected group of patients. Unfortunately, the progressive increase in waiting time for OLT may...
10.
Circadian variability of blood pressure in liver transplant recipients without antihypertensive therapy
Martinez-Rey C, Otero-Anton E, Tome S, Rodriguez-Framil M, Gonzalez-Quintela A, Calvo C, et al.
Transplant Proc . 2005 May; 37(3):1515-6. PMID: 15866660
Hypertension is a frequent cardiovascular risk factor in liver transplant recipients. The usefulness of ambulatory blood pressure monitoring (ABPM) in these patients is unknown. This study was aimed at evaluating...